Sorbonne Venture
Overview
Sorbonne Venture is a venture capital fund focused on deeptech and healthtech, dedicated to financing startups from the Sorbonne University ecosystem.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| EVerZom | Oct 2025 | Series A | Co-investor |
| AUSTRAL Dx | Jul 2025 | Seed | Lead |
| Biomemory | Dec 2024 | Series A | Co-investor |
| POLYGON Therapeutics | Nov 2024 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sorbonne Venture based?
Sorbonne Venture is headquartered in Paris, France.
When was Sorbonne Venture founded?
Sorbonne Venture was founded in 2023.
How many portfolio companies does Sorbonne Venture have?
Sorbonne Venture has 4 portfolio companies in Caplight's dataset.
What are some companies in Sorbonne Venture's portfolio?
Recent investments visible on Caplight include EVerZom, AUSTRAL Dx, Biomemory, POLYGON Therapeutics.
What was Sorbonne Venture's most recent investment?
Sorbonne Venture's most recent investment on Caplight was in EVerZom in 2025.
What sectors does Sorbonne Venture focus on?
Sorbonne Venture focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Sorbonne Venture focus on?
Sorbonne Venture typically invests at the Early stage.
What is Sorbonne Venture's AUM?
Sorbonne Venture's assets under management are estimated between $100.0M and $100.0M.